Coseal Spray Set
Baxter Bio Science · Decision date Aug 21, 2025
What did the FDA decide?
FDA records P030039/S031 as a supplement to PMA P030039, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 21, 2025.
FDA approval order statement
changing the cutting of the tubing from a manual to an automated process for the COSEAL Spray Set
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 21, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P030039/S031
- Regulatory pathway
- PMA supplement
- Applicant
- Baxter Bio Science
- Product code
- NBE
- Decision code
- OK30
- Decision date
- Aug 21, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sealant, polymerizing.
- Applicant
- Baxter Bio Science
- Product code
- NBE
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P030039/S031 received
Application receipt date recorded by FDA.
P030039/S031 · FDA decision
30-Day Notice
P030039/S032 · Related supplement
Coseal Applicator Tips
Timeline entries are records held by MedtechLedger for P030039. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030039
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Coseal Applicator TipsP030039/S032 | Baxter Bio Science | PMA supplement | Dec 18, 2025 | FDA |
Explore the linked device profile
Other records with product code NBE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PROGEL Pleural Air Leak SealantP010047/S073 | Neomend, Inc. | PMA supplement | Mar 12, 2026 | FDA |
TRIDYNE Vascular SealantP150016/S028 | Neomend, Inc. | PMA supplement | Mar 12, 2026 | FDA |
PROGEL Pleural Air Leak SealantP010047/S072 | Neomend, Inc. | PMA supplement | Dec 18, 2025 | FDA |
TRIDYNE Vascular SealantP150016/S027 | Neomend, Inc. | PMA supplement | Dec 18, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Baxter Bio Science
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 32650 N Wilson Rd., Mail Stop Wg2-3s, Round Lake,, IL, 60073
Sources and methodology
- Original FDA record: P030039/S031
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



